This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Bretaris Genuair
  • /
  • A Trial Assessing LAS34273 in Moderate to Severe S...
Clinical trial

A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)

Read time: 1 mins
Last updated:1st Aug 2006

To evaluate the efficacy and safety of LAS 34273 compared to placebo in patients with moderate to severe COPD during one year of treatment.


Study Type: Interventional
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
Official Title: Clinical Trial Assessing Efficacy and Safety of LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
Enrollment: 843
Study Start Date: August 2006
Study Completion Date: May 2008
Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)

Arms:
- Experimental:
Aclidinium 200 μg once-daily
- Placebo Comparator: Placebo

Category Value
Study start date 2006-08-01

View full details